INS and diabetes mellitus: Inhibition of digestive enzyme activity, reduction of gluconeogenesis, and enhancement of sensitivity to insulin or insulin secretion are considered to be the main mechanisms underlying the anti-DM activity of EOs (17)(Figure 2).